Alterations in peripheral blood level of TIMP-1, MMP-2 and MMP-9 in patients with type 2 diabetes

被引：0
|
作者：
Song, KE
Ahn, SM
Shin, DS
Lee, SW
Lee, HS
Song, BY
Kim, DJ
Chung, YS
Lee, KW
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A206 / A206
页数：1
相关论文
共 50 条
  • [21] Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis
    Zhongxin Jiang
    Tao Sui
    Bin Wang
    Rheumatology International, 2010, 30 : 1219 - 1226
  • [22] Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa
    Mori, Sachiko
    Pawankar, Ruby
    Ozu, Chika
    Nonaka, Manabu
    Yagi, Toshiaki
    Okubo, Kimihiro
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2012, 4 (04) : 231 - 239
  • [23] Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis
    Gomez, DE
    De Lorenzo, MS
    Alonso, DF
    Andrade, ZA
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (01): : 9 - 13
  • [24] MMP-2,MMP-9,TIMP-1和TIMP-2在肝癌中原位表达
    魏启幼
    吴元清
    范松青
    周金平
    湖南医科大学学报, 2003, (03) : 212 - 216
  • [25] Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis
    Pawlak, Krystyna
    Mysliwiec, Michal
    Pawlak, Dariusz
    CLINICAL BIOCHEMISTRY, 2011, 44 (10-11) : 838 - 843
  • [26] THE CLINICAL SIGNIFICANCE OF TIMP-1, TIMP-2, MMP-2, MMP-9, OSTEOPROTEGERIN, SRANKL, AND ISS IN MULTIPLE MYELOMA PATIENTS
    Oliveira, L. C.
    Uzielli, J. A.
    Baggio, M. S.
    Lange, A. P.
    Tanus-Santos, J. E.
    Rego, E. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 389 - 389
  • [27] The increased of MMP-9 and MMP-2 with the decreased of TIMP-1 on the uterosacral ligament after childbirth
    Rahajeng, Rahajeng
    PAN AFRICAN MEDICAL JOURNAL, 2018, 30
  • [28] Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves' orbitopathy
    Kapelko-Slowik, Katarzyna
    Slowik, Miroslaw
    Szalinski, Marek
    Dybko, Jaroslaw
    Wolowiec, Dariusz
    Prajs, Iwona
    Bohdanowicz-Pawlak, Anna
    Biernat, Monika
    Urbaniak-Kujda, Donata
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (01): : 99 - 103
  • [29] Expression of the matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in systemic lupus erythematosus patients
    Vira, H. J.
    Pradhan, V. D.
    Umare, V. D.
    Chaudhary, A. K.
    Rajadhyksha, A. G.
    Nadkar, M. Y.
    Ghosh, K.
    Nadkarni, A. H.
    NETHERLANDS JOURNAL OF MEDICINE, 2020, 78 (05): : 261 - 269
  • [30] The increased of MMP-9 and MMP-2 with the decreased of TIMP-1 on the uterosacral ligament after childbirth
    Rahajeng, Rahajeng
    PAN AFRICAN MEDICAL JOURNAL, 2018, 30
12345